Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

NCT05157971 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

B Acute Lymphoblastic Leukemia
Ph-Like Acute Lymphoblastic Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate

Sponsor

City of Hope Medical Center

Collaborators

[object Object]